Expanding genomic offerings Baylor Genetics has recently enhanced its Whole Genome Sequencing services by incorporating optical genome mapping and long-read sequencing technologies, presenting an opportunity to upsell advanced genetic testing solutions to clients seeking the latest diagnostic capabilities.

Government and healthcare contracts Securing a multi-year national contract with the US Department of Veterans Affairs demonstrates Baylor Genetics' strong reputation in providing comprehensive genetic testing services to large healthcare systems, indicating potential for expanding partnerships within government-funded programs.

Strategic industry presence Participation in key industry events like the PLUGS Summit and Child Neurology Society Conference highlights Baylor Genetics' active engagement with the healthcare and genetics communities, offering opportunities to connect with clinicians and institutions seeking innovative diagnostic solutions.

Diverse testing portfolio Offering a comprehensive menu that spans family planning, pediatric, oncology, and specialized testing allows for targeted sales of multiple genetic services, especially to clinics and hospitals focusing on personalized medicine and early diagnosis.

Market alignment and growth With revenues between 100 and 250 million dollars and a workforce of up to 1,000 employees, Baylor Genetics is well-positioned to scale its service delivery and explore new markets, presenting sales opportunities to enhance national coverage and technological integration in genetic testing.